Rx Bandz Wins Two Top Awards at BIONJ Conference
- Rx Bandz
- 9 hours ago
- 2 min read
Company Wins Best Company Presentation and Most Inspiring Presentation
We are honored that the judges recognized the value of our innovative next-generation platform technology for both investors and pharmaceutical companies to deliver their own proprietary formulation.”— Jessica Walsh, Founder/CEO, Rx Bandz
WASHINGTON, DC, UNITED STATES, March 26, 2025 /EINPresswire.com/ -- The innovative MiniJect is now part of the permanent collection of the National Museum of Health and Medicine, Washington DC.
DENVILLE, NJ, UNITED STATES, June 10, 2025 /EINPresswire.com/ -- Rx Bandz emerged as the competition standout at BioNJ’s 15th Annual BioPartnering Conference, taking home two of the event’s five top awards in a competitive field of 90 companies..
Selected as the winner for both the Best Company Presentation and Most Inspiring Presentation, Rx Bandz offers a disruptive auto-injector platform technology and a groundbreaking approach to life-saving formulations. These awards underscore the growing impact of Rx Bandz in reshaping the future of emergency medicine.
Sponsored by J.P. Morgan, Morgan Lewis, and CoreWeave, the conference brought together global investors, scientific pioneers, and industry leaders. The event, attended by nearly 600 leaders from 17 states and 7 countries, highlighted innovation across the biotech, healthcare, and digital health sectors.
Jessica Walsh, CEO of Rx Bandz, said, “We are honored that the judges recognized the value of our next-generation platform technology for both investors and pharmaceutical companies to deliver their own proprietary formulation. This versatility gives us many shots on goal in a $120B market. Our MiniJect® is the world’s smallest auto-injector capable of delivering a wide variety of drugs, including biologics and vaccines to treat both emergency and chronic medical conditions.
“The US military has funded our research and development to modify MiniJect for use on the battlefield. Our auto-injector is both compact and rugged, designed for Special Forces medics or an active 13-year old.”
Rx Bandz is currently in the final stage of its Series A. The company plans to submit its application for FDA approval in about a year. It is working with the New Jersey Economic Development Agency’s Evergreen Fund, which matches investments up to $4.2M and pays investors 2.5 percent in administrative fees and 30 percent in carried interest. It reserves $6M for follow-on investments. Investors do not have to be located in New Jersey to participate.
About Rx Bandz
Rx Bandz is a privately-held, woman-led biotech with its laboratory in Fairfield, NJ. Rx Bandz is developing the next generation of patient-centric auto-injectors to deliver a wide range of injectable medications around the world. Its MiniJect is the world’s smallest auto-injector that is safer, faster and easier-to-use than traditional auto-injectors. With products in development to treat numerous emergency medical conditions, Rx Bandz initially focused on delivering epinephrine to treat anaphylactic shock. The company is also formulating new drugs of various viscosities and molecular sizes for administration in its 1 ml to 5 ml auto-injectors.
For more information
see the company’s website at www.rxbandz.com
myrnawalsh@rxbandz.com +1 617-347-3475
Visit us on social media:LinkedIn
Comments